These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8517375)

  • 61. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
    La Noce A; Bertani F; Lorusso V; Luzzani F; Tirone P; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S43-50. PubMed ID: 8020518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [-Cervical myelography using the lumbar route-].
    Parlier-Cuau C; Wybier M; Moutounet L; Champsaur P; Laredo JD
    Ann Radiol (Paris); 1997; 40(2):99-103. PubMed ID: 9754339
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurological complications following myelography with water-soluble contrast medium.
    SODERBERG L; SJOBERG S; LANGELAND P
    Acta Orthop Scand; 1959; 28(3):220-3. PubMed ID: 13636839
    [No Abstract]   [Full Text] [Related]  

  • 64. Adhesive arachnoiditis following lumbar myelography.
    Skalpe IO
    Spine (Phila Pa 1976); 1978 Mar; 3(1):61-4. PubMed ID: 205956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W
    Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiology corner--canine myelography.
    Taeymans O; Saunders JH; van Bree H
    Vet Radiol Ultrasound; 2002; 43(6):550-1. PubMed ID: 12502109
    [No Abstract]   [Full Text] [Related]  

  • 67. Pantopaque intravasation (embolization) during myelography.
    TODD EM; GARDNER WJ
    J Neurosurg; 1957 Mar; 14(2):230-4. PubMed ID: 13416954
    [No Abstract]   [Full Text] [Related]  

  • 68. An evaluation of myelography with non-ionic water soluble contrast medium-iohexol.
    Yadav RK; Sharma A; Mishra DS; Airon RK; Kalra M; Dua S
    J Indian Med Assoc; 1999 Jan; 97(1):16-9. PubMed ID: 10549181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Acute decompensation in medullary tumor syndrome after myelography with a water-soluble contrast medium].
    KLOSS K; MORAWETZ H
    Z Orthop Ihre Grenzgeb; 1956; 87(4):638-44. PubMed ID: 13361381
    [No Abstract]   [Full Text] [Related]  

  • 70. Intrathecal gadolinium-enhanced MR myelography showing multiple dural leakages in a patient with Marfan syndrome.
    Kraemer N; Berlis A; Schumacher M
    AJR Am J Roentgenol; 2005 Jul; 185(1):92-4. PubMed ID: 15972406
    [No Abstract]   [Full Text] [Related]  

  • 71. Some observations on non-oily myelographic media.
    O'Malley BP
    Clin Radiol; 1965 Oct; 16(4):405-11. PubMed ID: 4284734
    [No Abstract]   [Full Text] [Related]  

  • 72. [Diagnostic error & permanent injury after myelography with iodized oil].
    WEISS R
    Fortschr Geb Rontgenstr Nuklearmed; 1958 Feb; 88(2):242-4. PubMed ID: 13512499
    [No Abstract]   [Full Text] [Related]  

  • 73. Modification in MRI contrast myelogram by instillation of intrathecal preservative-free normal saline to demonstrate CSF spinal leaks.
    Kootar S; Walavalkar A; Kumar A; Bhave C; Sanghvi D
    Neurol India; 2018; 66(4):1187-1189. PubMed ID: 30038122
    [No Abstract]   [Full Text] [Related]  

  • 74. Morphological changes of the brain following intrathecal application of contrast media.
    Schober R
    Acta Radiol Diagn (Stockh); 1966; 5():509-16. PubMed ID: 4289278
    [No Abstract]   [Full Text] [Related]  

  • 75. Epileptic seizures and EEG changes after radiculography with meglumine iothalamate (Conray) and meglumine iocarmate (Dimer-X). A case report.
    de Graaf AS; Kayed KS
    Psychiatr Neurol Neurochir; 1973; 76(2):77-82. PubMed ID: 4739808
    [No Abstract]   [Full Text] [Related]  

  • 76. Myelography using water-soluble contrast media as an outpatient procedure.
    de V van Niekerk JP
    S Afr Med J; 1979 Mar; 55(14):550-1. PubMed ID: 451783
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study.
    Behrends B; Albrecht A; Bingas B; Becker H; Brunke J; von Einsiedel H; Mariss G; Schmidt K; Thun F; Valavanis A
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():171-5. PubMed ID: 2568789
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Iotrolan. The first dimeric non-ionic contrast medium for the subarachnoid space.
    Wenzel-Hora BI
    Acta Radiol Suppl; 1986; 369():545-8. PubMed ID: 2980554
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Histological changes in myelography with positive contrast media].
    Hempel KJ; Zeitler E
    Radiologe; 1965 Dec; 5(12):508-12. PubMed ID: 4288506
    [No Abstract]   [Full Text] [Related]  

  • 80. [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
    Smaltino F; Ciccarelli R; Cirillo S; D'Auria T; Gambardella A; La Tessa G; Meoli S; Rotondo A; Santoro S
    Radiol Med; 1980 Apr; 66(4):203-10. PubMed ID: 7005985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.